Therapeutic Applications of Ion Exchange Resins

[1]  R. Doijad,et al.  An Approch For Development Of Oral Sustained Release Suspension , 2011 .

[2]  S. Kadam,et al.  Molecular properties of ciprofloxacin-indion 234 complexes , 2004, AAPS PharmSciTech.

[3]  S. Kadam,et al.  Drug release properties of polyethylene-glycol-treated ciprofloxacin-Indion 234 complexes , 2004, AAPS PharmSciTech.

[4]  H. Nakano,et al.  Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia. , 2007, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[5]  J. Pandit,et al.  Controlled release formulations in neurology practice , 2006 .

[6]  K. Murata,et al.  An Organic Acid-Induced Sigmoidal Release System for Oral Controlled-Release Preparations , 2004, Pharmaceutical Research.

[7]  M. Hussain,et al.  Hollow Fibers as an Oral Sustained-Release Delivery System , 2004, Pharmaceutical Research.

[8]  S. Davis,et al.  Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Haas,et al.  A New Method of Characterizing the Buccal Dissolution of Drugs , 2002 .

[10]  E. Yonemochi,et al.  Molecular Properties of Propranolol Hydrochloride Prepared as Drug-Resin Complexes , 2001, Drug development and industrial pharmacy.

[11]  J. Fell,et al.  Prolonged Gastric Retention Using Floating Dosage Forms , 2000 .

[12]  R. Bodmeier,et al.  Effect of ion exchange resins on the drug release from matrix tablets. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  R. O'Callaghan,et al.  Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. , 1998, Current eye research.

[14]  F. Atyabi,et al.  Controlled drug release from coated floating ion exchange resin beads , 1996 .

[15]  H. Yoshino,et al.  An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. , 1996, Journal of pharmaceutical sciences.

[16]  R. Steele,et al.  Intragastric Distribution of Ion‐exchange Resins: a Drug Delivery System for the Topical Treatment of the Gastric Mucosa , 1995, The Journal of pharmacy and pharmacology.

[17]  Jay A. Miers.  Regulation of ion exchange resins for the food, water and beverage industries , 1995 .

[18]  M. Kurowski,et al.  The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients. , 1994, International journal of clinical pharmacology and therapeutics.

[19]  Y. Ali,et al.  Ion exchange resins for ophthalmic delivery. , 1994, Journal of ocular pharmacology.

[20]  I. Martins,et al.  Evaluation of Ion‐exchange Microspheres as Carriers for the Anticancer Drug Doxorubicin: In‐vitro Studies , 1992, The Journal of pharmacy and pharmacology.

[21]  J. Benoit,et al.  Binding mechanism of doxorubicin in ion-exchange albumin microcapsules. , 1987, Journal of pharmaceutical sciences.

[22]  Vincent Li.  Influence of Drug Properties and Routes of Drug Administration on the Design of Sustained and Controlled Release Systems , 1987 .

[23]  W. Craig,et al.  Effect of free fatty acids on protein binding of antimicrobial agents. , 1981, The Journal of infectious diseases.

[24]  M. Rudnick,et al.  Partial purification and characterization of the drug-binding-defect inducer in uremia. , 1981, The Journal of laboratory and clinical medicine.

[25]  W. Craig,et al.  Correction of protein binding defect in uremic sera by charcoal treatment. , 1976, The Journal of laboratory and clinical medicine.

[26]  M. Royer,et al.  In vitro binding of drugs to colestipol hydrochloride. , 1974, Journal of pharmaceutical sciences.

[27]  N. J. van Abbé,et al.  Amberlite resin XE-88 as a tablet disintegrant. , 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[28]  W. Payne.  ION EXCHANGE RESINS IN CLINICAL MEDICINE , 1956, The Journal of pharmacy and pharmacology.

[29]  N. Chaudhry,et al.  SUSTAINED RELEASE OF DRUGS FROM ION EXCHANGE RESINS , 1956, The Journal of pharmacy and pharmacology.

[30]  M. Biswas,et al.  [Synthetic ion exchange resins]. , 1953, Athena; rassegna mensile di biologia, clinica e terapia.

[31]  B. L. Martz,et al.  Use of a Combination of Anion and Cation Exchange Resins in the Treatment of Edema and Ascites , 1952, Circulation.

[32]  W. H. Bonner.  The Flying Dutchman of the Western World , 1946 .